Skip to main content
logo
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
4.080
+0.630 (18.26%)
Aug 4, 2026, 11:37 AM EDT - Market open

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
59151017217
Market Cap Growth
-65.02%-37.62%55.01%-40.96%-92.39%3178.60%
Enterprise Value
-4.768.0314.0644.026.25202.76
Last Close Price
4.0830.00110.25675.001207.5031275.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--25.96143.34--
PB Ratio
0.593.938.884.361.368.51
P/TBV Ratio
0.2521.20-50.57--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--24.17647.29--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.120.2817.750.070.09
Net Debt / Equity Ratio
-1.28-0.58-0.6115.35-0.85-0.56
Net Debt / EBITDA Ratio
0.730.150.07-1.630.310.13
Net Debt / FCF Ratio
1.220.200.06-1.680.480.60
Asset Turnover
-00.020.0000
Quick Ratio
2.680.880.741.221.624.81
Current Ratio
2.891.010.801.461.795.10
Return on Equity (ROE)
-245.94%-686.69%-2264.31%-302.20%-130.71%-739.07%
Return on Assets (ROA)
-149.93%-168.40%-57.59%-59.20%-123.25%-511.68%
Return on Invested Capital (ROIC)
--1124.32%-84.31%-110.25%-506.82%-1127.26%
Return on Capital Employed (ROCE)
-248.35%-368.92%-69.83%-73.92%-156.41%-604.49%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-507.35%-593.08%-157.06%---
Total Shareholder Return
-507.35%-593.08%-157.06%---
SEC Filings: 10-K · 10-Q